Dr. Lal Path Labs Ltd. (LALPATHLAB) cleared its 6M resistance trendline, gaining 5% intraday. The stock is now above resistance at ₹1738, showing a strong up.
Dr. Lal Path Labs Ltd. (LALPATHLAB) reports a 19.1% revenue growth and 27.2% PAT increase in Q1 FY27.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 10% intraday. The stock cleared its 6M resistance trendline, marking a strong upward move in th.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock clears its 6M resistance trendline, gaining 10% intraday. This breakout signals a strong upward trend in the health.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 9% intraday. The stock cleared its 6M resistance trendline, signaling a strong upward move in t.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 8% intraday, clearing its 6M resistance trendline in the healthcare diagnostics sector.